Literature DB >> 8879600

Hypertension in pregnancy and size at birth.

K Himmelmann1, A Himmelmann, A Niklasson, A Svensson.   

Abstract

Low birth weight and high placental weight are associated with increased cardiovascular morbidity and mortality. Children born after hypertensive pregnancies have higher blood pressure than children born after normotensive pregnancies. Hypertension in pregnancy is considered a major risk factor for intrauterine growth retardation. The present study describes size at birth and perinatal characteristics in children born after hypertensive pregnancies. During five consecutive years 17,000 deliveries took place in the well defined geographic area of eastern Göteborg. Hypertension in pregnancy complicated 261 pregnancies. For comparison 260 normotensive pregnancies, matched for maternal age and time of delivery, were used. Standard deviation score for birth weight and length were calculated according to reference standards for birth weight (BWSDS) and length (BLSDS) based on all Swedish births 1977-1981 (n = 475,588). Children born after hypertensive pregnancies had lower birth weight, were shorter and had a shorter gestational period as compared with children born after normotensive pregnancies. Head circumference and placental weight did not differ and there were no significant differences in BWSDS. It is concluded that hypertensive pregnancies are characterized by lower birth weight and shorter gestational period. However, intrauterine growth retardation is not a general characteristic of hypertension in pregnancy.

Entities:  

Mesh:

Year:  1996        PMID: 8879600     DOI: 10.3109/08037059609078060

Source DB:  PubMed          Journal:  Blood Press        ISSN: 0803-7051            Impact factor:   2.835


  1 in total

1.  Expression of ABC transporters during syncytialization in preeclampsia.

Authors:  Visalakshi Sethuraman; Yong Pu; Jeremy Gingrich; Jiongjie Jing; Robert Long; Isoken Nicholas Olomu; Almudena Veiga-Lopez
Journal:  Pregnancy Hypertens       Date:  2022-01-31       Impact factor: 2.494

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.